Navigation Links
Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
Date:5/11/2011

>

In response to rising healthcare expenditure, governments in developed markets are looking bolster generic uptake in order to contain costs. Physician prescribing by international non-proprietary name (INN), in addition to automatic substitution and pharmacist incentives, are key tools to drive generic uptake.

In the US, despite the addition of many new customers and the continued drive to increase generic uptake as a result of the healthcare reform law, generics companies are set to experience further downward pricing pressures and will be forced to operate with ever-decreasing margins, focusing on consolidation and cost-cutting.

The BRIC countries represent a key growth market for the generics industry. Uptake of generics in these markets will be driven by continued population expansion, increased prosperity, and expanding healthcare coverage.

Your key questions answered

* Evaluate the drivers and resistors to generic uptake in the US, EU, Japan and BRIC markets

* Gain insight into the deal types between companies to bolster their position in generics markets

* Identify which key small molecules are facing patent expiry and provide opportunities for generic producers

Executive Summary

Key findings

Prescription pharmaceuticals sales and growth rate analysis, 2003–15

Operating costs and profit analysis

Shionogi: PharmaVitae forecasts at a glance

Strategic insight

Focus on "core strategic" product lines

Late-stage pipeline products Shionogi's launch portfolio consists of 10 products, six of which have already come to market – Cymbalta, Pirespa (pirfenidone), Rapiacta (peramivir), Kapvay (clonidine hydrochloride), and Cuvposa (glycopyrrolate) – indicating its success in launching late-stage products. Furthermore, over 2009–15, Shionogi plans to file New Drug Applications (NDAs) for at least four late-stage pipeline products (S-34957
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds Markets for Emerging Pharmaceutical Technologies
2. Reportlinker Adds Orthopedic Devices Market in the Emerging Countries (China, India, Brazil) - Presenting New Avenues for Growth and Profitability
3. Reportlinker Adds Medical Imaging Reports Bundle
4. Reportlinker Adds Fetal Monitoring, Diagnostics and Predictive Tests
5. Reportlinker Adds KOL insights and unmet needs in Ulcerative Colitis and Crohns Disease
6. Reportlinker Adds U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments
7. Reportlinker Adds Brazil Biomaterial Market (2010 - 2015)
8. Reportlinker Adds Minimally Invasive Surgical Devices, World Market
9. Reportlinker Adds Triple Analysis: Breast Cancer, Leukemia and Cancer Vaccines
10. Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Pancreatic Cancer
11. Reportlinker Adds European Market for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... NEW YORK and HERZLIYA PITUACH, Israel, Nov. ... IMNP; "Immune" or "the Company"), a clinical stage ... commercialization of targeted therapeutics for the treatment of ... of its previously announced underwritten public offering of ... share of the Company,s common stock, par value ...
(Date:11/24/2014)... Nov. 24, 2014  CryoLife, Inc. (NYSE: CRY ... on cardiac and vascular surgery, announced today that it will ... Healthcare Conference on Wednesday, December 3, 2014 at The New ... . A live webcast of the Company,s presentation ... feature an overview of the company by Pat Mackin ...
(Date:11/24/2014)... Colo. , Nov. 24, 2014 ... Inc. (NYSE MKT: AMPE), today announced the presentation ... RedoxSYS™ Diagnostic System as a broadly applicable and ... (ORP) in the body in response to injury, ... were performed in collaboration with Luoxis, academic and ...
Breaking Medicine Technology:Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 2Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 4Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 5
(Date:11/26/2014)... November 26, 2014 Loffler Companies has ... Week in Imaging, an online information and news publication ... is the sixth consecutive year Loffler has earned this ... , The Elite Dealer Awards honor the best and ... year’s Elite Dealer honorees were chosen for their innovative ...
(Date:11/26/2014)... Senior Planning Services, providing “expert guidance ... organization providing the adult demographic education and access ... navigate the rough seas of applying for Medicaid. Part ... the topic of Medicaid eligibility and proper planning, while ... applying for this coverage. , Senior Planning Services ...
(Date:11/26/2014)... November 26, 2014 Call 866-997-4948 (Us-Canada ... or email the details on sales(at)researchmoz(dot)us , Researchmoz.us ... drug discovery market 2014" with deep study of the ... result of high blood sugar. The global glucose monitoring ... to the growing number of diabetics in the world. ...
(Date:11/26/2014)... Baton Rouge, Louisiana (PRWEB) November 26, 2014 ... and neck pain relief and specialists in minimally ... Dr. K. Samer Shamieh into the rapidly growing ... management specialists. The addition coincides with the ... cutting-edge, reliable medical treatment for Louisiana residents who ...
(Date:11/26/2014)... News) -- Youngsters who enter puberty early are at ... Early puberty was linked with a number of factors ... anxiety levels, according to the researchers. Early puberty was ... family and peers, and having friends who were prone ... the study found an association between early puberty and ...
Breaking Medicine News(10 mins):Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2
... the drug Rimonabant (Acomplia) a selective cannabinoid receptor blocker ... . Supplementation with 20 milligrams of rimonabant a day ... waist circumference -- a marker of cardiovascularly dangerous visceral ... the prevalence of metabolic syndrome in overweight/obese patients. ...
... to avoid medical mistakes, but now it seems computerized prescription ... is known that adverse drug events injure or kill more ... are trying to cut back on that number is with ... use of computerized systems may actually be leading to more ...
... gradually increased recommendations for daily calcium intake, largely from ... to promote healthy bones and prevent osteoporosis. But a ... of milk or other dairy products was not necessarily ... of at least 400 milligrams per day. ,Other ...
... us have not forgotten the thalidomide tragedy thalidomide in the ... morning sickness // to pregnant mothers and resulted in seal ... future use for the infamous medication: helping cancer patients maintain ... in pancreatic cancer patients and was seen to help ...
... cell research that will help in numerous therapies using stem ... human embryonic stem cells in the laboratory. ,Human ... role in regeneration of cells for therapeutic use. However, while ... animal cells and serum and run the risk of being ...
... say they have now identified a gene variant that ... which in turn could lead to improved understanding of ... to latest research it was seen that specific changes ... associated with an increased incidence of Alzheimer’s. ,In ...
Cached Medicine News:
... Coat-A-Count Estradiol is,a ... for in vitro,diagnostic use ... estradiol in serum, for ... and,for monitoring of ovulation ...
... Estradiol (E2) is the most potent, ... estrogen produced by the ovary [1]. In ... [1,2], and from estrone, a less potent ... are interconverted in many body tissues. In ...
... is the most potent, naturally secreted estrogen ... the ovary [1]. In the ovary, estradiol ... estrone, a less potent estrogen derived from ... many body tissues. In men, small amounts ...
For the quantitative measurement of CKMB, Myoglobin, and Troponin-I in human serum....
Medicine Products: